Rank | Gene Set | Z-score |
---|---|---|
1 | exogenous drug catabolic process (GO:0042738) | 7.57888303 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.56968055 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.56968055 |
4 | L-phenylalanine metabolic process (GO:0006558) | 7.22827311 |
5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.22827311 |
6 | epoxygenase P450 pathway (GO:0019373) | 7.12014077 |
7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.95196268 |
8 | aromatic amino acid family catabolic process (GO:0009074) | 6.74894726 |
9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.45456967 |
10 | indole-containing compound catabolic process (GO:0042436) | 6.07963914 |
11 | indolalkylamine catabolic process (GO:0046218) | 6.07963914 |
12 | tryptophan catabolic process (GO:0006569) | 6.07963914 |
13 | kynurenine metabolic process (GO:0070189) | 5.97990443 |
14 | negative regulation of fibrinolysis (GO:0051918) | 5.90284118 |
15 | bile acid biosynthetic process (GO:0006699) | 5.87428168 |
16 | glyoxylate metabolic process (GO:0046487) | 5.85162144 |
17 | tryptophan metabolic process (GO:0006568) | 5.73045974 |
18 | urea cycle (GO:0000050) | 5.72199706 |
19 | urea metabolic process (GO:0019627) | 5.72199706 |
20 | regulation of protein activation cascade (GO:2000257) | 5.71664650 |
21 | regulation of fibrinolysis (GO:0051917) | 5.69090908 |
22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.65862279 |
23 | complement activation, alternative pathway (GO:0006957) | 5.59460439 |
24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.54336799 |
25 | protein carboxylation (GO:0018214) | 5.51622180 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.51622180 |
27 | cysteine metabolic process (GO:0006534) | 5.35658340 |
28 | sulfur amino acid catabolic process (GO:0000098) | 5.28755443 |
29 | regulation of plasminogen activation (GO:0010755) | 5.26490030 |
30 | regulation of complement activation (GO:0030449) | 5.25833255 |
31 | nitrogen cycle metabolic process (GO:0071941) | 5.25353078 |
32 | * positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.24202441 |
33 | drug metabolic process (GO:0017144) | 5.09374445 |
34 | serine family amino acid catabolic process (GO:0009071) | 5.09214249 |
35 | regulation of humoral immune response (GO:0002920) | 5.08402013 |
36 | reverse cholesterol transport (GO:0043691) | 5.03725536 |
37 | bile acid metabolic process (GO:0008206) | 5.03386407 |
38 | regulation of cholesterol esterification (GO:0010872) | 4.93274226 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.93222077 |
40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.90786380 |
41 | protein-lipid complex remodeling (GO:0034368) | 4.90786380 |
42 | macromolecular complex remodeling (GO:0034367) | 4.90786380 |
43 | aromatic amino acid family metabolic process (GO:0009072) | 4.90137790 |
44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86866401 |
45 | tyrosine metabolic process (GO:0006570) | 4.79263007 |
46 | homocysteine metabolic process (GO:0050667) | 4.76170198 |
47 | negative regulation of hemostasis (GO:1900047) | 4.75792985 |
48 | negative regulation of blood coagulation (GO:0030195) | 4.75792985 |
49 | acylglycerol homeostasis (GO:0055090) | 4.70963376 |
50 | triglyceride homeostasis (GO:0070328) | 4.70963376 |
51 | phospholipid efflux (GO:0033700) | 4.67680556 |
52 | oxidative demethylation (GO:0070989) | 4.67293628 |
53 | ethanol metabolic process (GO:0006067) | 4.62079325 |
54 | alpha-amino acid catabolic process (GO:1901606) | 4.60341115 |
55 | amino-acid betaine metabolic process (GO:0006577) | 4.55830714 |
56 | lysine metabolic process (GO:0006553) | 4.54299717 |
57 | lysine catabolic process (GO:0006554) | 4.54299717 |
58 | intestinal cholesterol absorption (GO:0030299) | 4.53739212 |
59 | negative regulation of cholesterol transport (GO:0032375) | 4.52080172 |
60 | negative regulation of sterol transport (GO:0032372) | 4.52080172 |
61 | plasma lipoprotein particle clearance (GO:0034381) | 4.49097776 |
62 | glycine metabolic process (GO:0006544) | 4.40102391 |
63 | cellular ketone body metabolic process (GO:0046950) | 4.39282267 |
64 | bile acid and bile salt transport (GO:0015721) | 4.36448044 |
65 | negative regulation of coagulation (GO:0050819) | 4.34873512 |
66 | cholesterol efflux (GO:0033344) | 4.34689454 |
67 | imidazole-containing compound metabolic process (GO:0052803) | 4.34586566 |
68 | coenzyme catabolic process (GO:0009109) | 4.31654579 |
69 | indolalkylamine metabolic process (GO:0006586) | 4.30874830 |
70 | negative regulation of wound healing (GO:0061045) | 4.30130221 |
71 | glutamate metabolic process (GO:0006536) | 4.25937866 |
72 | cellular amino acid catabolic process (GO:0009063) | 4.22201546 |
73 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.21616789 |
74 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.21616789 |
75 | cellular biogenic amine catabolic process (GO:0042402) | 4.19958494 |
76 | amine catabolic process (GO:0009310) | 4.19958494 |
77 | fibrinolysis (GO:0042730) | 4.19405471 |
78 | serine family amino acid metabolic process (GO:0009069) | 4.16010971 |
79 | plasma lipoprotein particle assembly (GO:0034377) | 4.13410273 |
80 | positive regulation of hemostasis (GO:1900048) | 4.11263050 |
81 | positive regulation of blood coagulation (GO:0030194) | 4.11263050 |
82 | protein-lipid complex subunit organization (GO:0071825) | 4.11055974 |
83 | cellular glucuronidation (GO:0052695) | 4.09094419 |
84 | regulation of apoptotic cell clearance (GO:2000425) | 4.07922002 |
85 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07135265 |
86 | blood coagulation, intrinsic pathway (GO:0007597) | 4.06398942 |
87 | phenylpropanoid metabolic process (GO:0009698) | 4.06274785 |
88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.05850257 |
89 | cellular modified amino acid catabolic process (GO:0042219) | 4.05213139 |
90 | benzene-containing compound metabolic process (GO:0042537) | 4.04520278 |
91 | serine family amino acid biosynthetic process (GO:0009070) | 4.02966147 |
92 | arginine metabolic process (GO:0006525) | 4.02089324 |
93 | negative regulation of protein activation cascade (GO:2000258) | 4.01322670 |
94 | aldehyde catabolic process (GO:0046185) | 4.00393120 |
95 | ethanol oxidation (GO:0006069) | 3.95824468 |
96 | protein activation cascade (GO:0072376) | 3.91895158 |
97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.91182706 |
98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.91182706 |
99 | complement activation, classical pathway (GO:0006958) | 3.90904028 |
100 | acute-phase response (GO:0006953) | 3.89687260 |
101 | complement activation (GO:0006956) | 3.86989312 |
102 | phospholipid homeostasis (GO:0055091) | 3.85216239 |
103 | drug catabolic process (GO:0042737) | 3.81022538 |
104 | negative regulation of complement activation (GO:0045916) | 3.80688300 |
105 | ketone body metabolic process (GO:1902224) | 3.80076862 |
106 | heme transport (GO:0015886) | 3.80047262 |
107 | cofactor catabolic process (GO:0051187) | 3.79105430 |
108 | positive regulation of coagulation (GO:0050820) | 3.79081555 |
109 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.79070220 |
110 | cholesterol homeostasis (GO:0042632) | 3.78239173 |
111 | positive regulation of lipid catabolic process (GO:0050996) | 3.77790111 |
112 | acute inflammatory response (GO:0002526) | 3.77001984 |
113 | plasma lipoprotein particle organization (GO:0071827) | 3.74958788 |
114 | negative regulation of lipase activity (GO:0060192) | 3.74826147 |
115 | S-adenosylmethionine metabolic process (GO:0046500) | 3.74632103 |
116 | opsonization (GO:0008228) | 3.73036741 |
117 | sterol homeostasis (GO:0055092) | 3.71985428 |
118 | protein-lipid complex assembly (GO:0065005) | 3.70442667 |
119 | regulation of cholesterol homeostasis (GO:2000188) | 3.69857731 |
120 | cytolysis (GO:0019835) | 3.69644608 |
121 | carboxylic acid catabolic process (GO:0046395) | 3.68212486 |
122 | organic acid catabolic process (GO:0016054) | 3.68212486 |
123 | regulation of bile acid biosynthetic process (GO:0070857) | 3.67365003 |
124 | glucuronate metabolic process (GO:0019585) | 3.62145569 |
125 | uronic acid metabolic process (GO:0006063) | 3.62145569 |
126 | acetyl-CoA metabolic process (GO:0006084) | 3.59894047 |
127 | flavonoid metabolic process (GO:0009812) | 3.56693793 |
128 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.52374921 |
129 | lipoprotein metabolic process (GO:0042157) | 3.49154790 |
130 | hormone catabolic process (GO:0042447) | 3.48150708 |
131 | regulation of acute inflammatory response (GO:0002673) | 3.41898729 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37762805 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18310848 |
3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.98918732 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50188770 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.32834058 |
6 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.19333990 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80863193 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.13425568 |
9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.05371768 |
10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06122846 |
11 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0692905 |
12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99384867 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93699431 |
14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.62762865 |
15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.57932595 |
16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51782234 |
17 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.42166416 |
18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41221059 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39073151 |
20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.33424415 |
21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28841362 |
22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.20469024 |
23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19967349 |
24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19601965 |
25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.16164756 |
26 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.02677521 |
27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01181679 |
28 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99103438 |
29 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97920032 |
30 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94154597 |
31 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93328366 |
32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.92075247 |
33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91353686 |
34 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90233817 |
35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87114094 |
36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.86178410 |
37 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82919951 |
38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82147888 |
39 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.81620366 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81403978 |
41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79128110 |
42 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78490942 |
43 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77228622 |
44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75125054 |
45 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74135714 |
46 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.73850773 |
47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73352195 |
48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72050720 |
49 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71885449 |
50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.71856347 |
51 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70125136 |
52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69674271 |
53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.69519203 |
54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68319919 |
55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67692109 |
56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66743824 |
57 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.65707957 |
58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63426558 |
59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63426558 |
60 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.62237492 |
61 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62114741 |
62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60821498 |
63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.60006681 |
64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59273727 |
65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.58862566 |
66 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.58370795 |
67 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57892558 |
68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57838941 |
69 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.57407693 |
70 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56302507 |
71 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56100994 |
72 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.55686583 |
73 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.55371800 |
74 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55199612 |
75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.55037880 |
76 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.54936710 |
77 | TP53_16413492_ChIP-PET_HCT116_Human | 0.54662207 |
78 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54161608 |
79 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53794030 |
80 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.53147699 |
81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.52658838 |
82 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52214118 |
83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.52178369 |
84 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.51922134 |
85 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.51876494 |
86 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.51800405 |
87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51679285 |
88 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.51659910 |
89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.51090549 |
90 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50517280 |
91 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.50300294 |
92 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49310475 |
93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49211706 |
94 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.49010884 |
95 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.47728474 |
96 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.47541060 |
97 | CBP_21632823_ChIP-Seq_H3396_Human | 0.47152238 |
98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.47052530 |
99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.46782194 |
100 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.46396634 |
101 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45906597 |
102 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45807644 |
103 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45219893 |
104 | NFYA_21822215_ChIP-Seq_K562_Human | 0.44913392 |
105 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44851721 |
106 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.44239864 |
107 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.43989937 |
108 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.43961971 |
109 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43241094 |
110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43015414 |
111 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42573807 |
112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42513374 |
113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42262075 |
114 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41606394 |
115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41469991 |
116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.40778791 |
117 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.40511413 |
118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40263487 |
119 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40138718 |
120 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39716050 |
121 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39449853 |
122 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38608478 |
123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38192162 |
124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37378502 |
125 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37114241 |
126 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.36325967 |
127 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34281876 |
128 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.33888274 |
129 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.33562184 |
130 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33552362 |
131 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.33333859 |
132 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.32948138 |
133 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.32868467 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.16259146 |
2 | MP0005360_urolithiasis | 7.50456928 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.42384532 |
4 | MP0005365_abnormal_bile_salt | 6.11068538 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.02243748 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.26289197 |
7 | MP0003252_abnormal_bile_duct | 3.89005220 |
8 | MP0010329_abnormal_lipoprotein_level | 3.64597781 |
9 | MP0009840_abnormal_foam_cell | 3.33293770 |
10 | MP0005083_abnormal_biliary_tract | 3.18123004 |
11 | MP0003195_calcinosis | 2.82556812 |
12 | MP0005332_abnormal_amino_acid | 2.73528135 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.60368718 |
14 | MP0001666_abnormal_nutrient_absorption | 2.58695380 |
15 | MP0000609_abnormal_liver_physiology | 2.20450954 |
16 | MP0004019_abnormal_vitamin_homeostasis | 2.13225542 |
17 | MP0002118_abnormal_lipid_homeostasis | 2.10458671 |
18 | MP0002138_abnormal_hepatobiliary_system | 1.98677272 |
19 | MP0003868_abnormal_feces_composition | 1.88058054 |
20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82379197 |
21 | MP0001764_abnormal_homeostasis | 1.64074384 |
22 | MP0009697_abnormal_copulation | 1.60426223 |
23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57469664 |
24 | MP0003011_delayed_dark_adaptation | 1.50927225 |
25 | MP0005451_abnormal_body_composition | 1.37871792 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.34863060 |
27 | MP0003186_abnormal_redox_activity | 1.24082576 |
28 | MP0009643_abnormal_urine_homeostasis | 1.21924854 |
29 | MP0000598_abnormal_liver_morphology | 1.21112145 |
30 | MP0003705_abnormal_hypodermis_morpholog | 1.19669713 |
31 | MP0000604_amyloidosis | 1.18451503 |
32 | MP0001915_intracranial_hemorrhage | 1.14239463 |
33 | MP0002254_reproductive_system_inflammat | 1.13418356 |
34 | MP0005647_abnormal_sex_gland | 1.12454093 |
35 | MP0009764_decreased_sensitivity_to | 1.09419465 |
36 | MP0009763_increased_sensitivity_to | 1.07270527 |
37 | MP0010368_abnormal_lymphatic_system | 1.06026383 |
38 | MP0005636_abnormal_mineral_homeostasis | 0.94786126 |
39 | MP0008469_abnormal_protein_level | 0.92408999 |
40 | MP0009642_abnormal_blood_homeostasis | 0.88681572 |
41 | MP0005058_abnormal_lysosome_morphology | 0.87694286 |
42 | MP0005408_hypopigmentation | 0.84589489 |
43 | MP0003122_maternal_imprinting | 0.83736024 |
44 | MP0005670_abnormal_white_adipose | 0.81288823 |
45 | MP0009765_abnormal_xenobiotic_induced | 0.80901040 |
46 | MP0005376_homeostasis/metabolism_phenot | 0.79873195 |
47 | MP0005084_abnormal_gallbladder_morpholo | 0.79210131 |
48 | MP0006036_abnormal_mitochondrial_physio | 0.78946025 |
49 | MP0005023_abnormal_wound_healing | 0.77909439 |
50 | MP0002078_abnormal_glucose_homeostasis | 0.77754125 |
51 | MP0004272_abnormal_basement_membrane | 0.77545340 |
52 | MP0005220_abnormal_exocrine_pancreas | 0.77348617 |
53 | MP0002971_abnormal_brown_adipose | 0.74430444 |
54 | MP0000566_synostosis | 0.72327955 |
55 | MP0001661_extended_life_span | 0.72214345 |
56 | MP0002876_abnormal_thyroid_physiology | 0.71906328 |
57 | MP0003690_abnormal_glial_cell | 0.69477046 |
58 | MP0002282_abnormal_trachea_morphology | 0.69431319 |
59 | MP0005334_abnormal_fat_pad | 0.68576819 |
60 | MP0009053_abnormal_anal_canal | 0.68471638 |
61 | MP0002089_abnormal_postnatal_growth/wei | 0.67142612 |
62 | MP0003879_abnormal_hair_cell | 0.66721831 |
63 | MP0004130_abnormal_muscle_cell | 0.66348675 |
64 | MP0005535_abnormal_body_temperature | 0.65441749 |
65 | MP0005464_abnormal_platelet_physiology | 0.64753583 |
66 | MP0000639_abnormal_adrenal_gland | 0.63483996 |
67 | MP0005266_abnormal_metabolism | 0.62951179 |
68 | MP0003329_amyloid_beta_deposits | 0.61912508 |
69 | MP0001756_abnormal_urination | 0.57399557 |
70 | MP0006035_abnormal_mitochondrial_morpho | 0.55805263 |
71 | MP0005448_abnormal_energy_balance | 0.55554237 |
72 | MP0005187_abnormal_penis_morphology | 0.54408082 |
73 | MP0005395_other_phenotype | 0.51821441 |
74 | MP0003436_decreased_susceptibility_to | 0.49913038 |
75 | MP0003724_increased_susceptibility_to | 0.48031323 |
76 | MP0003638_abnormal_response/metabolism_ | 0.46027244 |
77 | MP0002928_abnormal_bile_duct | 0.45679250 |
78 | MP0008873_increased_physiological_sensi | 0.45588668 |
79 | MP0002136_abnormal_kidney_physiology | 0.45572223 |
80 | MP0003718_maternal_effect | 0.45337956 |
81 | MP0003941_abnormal_skin_development | 0.44900592 |
82 | MP0005409_darkened_coat_color | 0.44877414 |
83 | MP0002822_catalepsy | 0.44370708 |
84 | MP0008874_decreased_physiological_sensi | 0.43376198 |
85 | MP0003075_altered_response_to | 0.42687534 |
86 | MP0003632_abnormal_nervous_system | 0.41473773 |
87 | MP0001986_abnormal_taste_sensitivity | 0.41268988 |
88 | MP0005166_decreased_susceptibility_to | 0.40869284 |
89 | MP0000920_abnormal_myelination | 0.40602770 |
90 | MP0000579_abnormal_nail_morphology | 0.40076614 |
91 | MP0003953_abnormal_hormone_level | 0.39931166 |
92 | MP0009384_cardiac_valve_regurgitation | 0.39431917 |
93 | MP0002837_dystrophic_cardiac_calcinosis | 0.39353152 |
94 | MP0005248_abnormal_Harderian_gland | 0.38935471 |
95 | MP0004782_abnormal_surfactant_physiolog | 0.38166103 |
96 | MP0002249_abnormal_larynx_morphology | 0.37998962 |
97 | MP0005666_abnormal_adipose_tissue | 0.37799111 |
98 | MP0004381_abnormal_hair_follicle | 0.34974257 |
99 | MP0009672_abnormal_birth_weight | 0.34927700 |
100 | MP0008872_abnormal_physiological_respon | 0.34563051 |
101 | MP0004883_abnormal_blood_vessel | 0.34520863 |
102 | MP0000249_abnormal_blood_vessel | 0.33852327 |
103 | MP0002796_impaired_skin_barrier | 0.33686898 |
104 | MP0002128_abnormal_blood_circulation | 0.32534782 |
105 | MP0009115_abnormal_fat_cell | 0.32511340 |
106 | MP0003123_paternal_imprinting | 0.32496334 |
107 | MP0001243_abnormal_dermal_layer | 0.32098424 |
108 | MP0006082_CNS_inflammation | 0.31749990 |
109 | MP0002168_other_aberrant_phenotype | 0.31163173 |
110 | MP0002970_abnormal_white_adipose | 0.30838807 |
111 | MP0003172_abnormal_lysosome_physiology | 0.30414214 |
112 | MP0003633_abnormal_nervous_system | 0.30299692 |
113 | MP0001845_abnormal_inflammatory_respons | 0.30182107 |
114 | MP0001881_abnormal_mammary_gland | 0.30042555 |
115 | MP0000230_abnormal_systemic_arterial | 0.29636267 |
116 | MP0001853_heart_inflammation | 0.29287949 |
117 | MP0005164_abnormal_response_to | 0.29083010 |
118 | MP0009785_altered_susceptibility_to | 0.28558876 |
119 | MP0000467_abnormal_esophagus_morphology | 0.27159417 |
120 | MP0003631_nervous_system_phenotype | 0.26988833 |
121 | MP0004264_abnormal_extraembryonic_tissu | 0.26489576 |
122 | MP0001944_abnormal_pancreas_morphology | 0.26350756 |
123 | MP0000427_abnormal_hair_cycle | 0.26280720 |
124 | MP0002132_abnormal_respiratory_system | 0.26140245 |
125 | MP0003699_abnormal_female_reproductive | 0.25520222 |
126 | MP0002909_abnormal_adrenal_gland | 0.24588166 |
127 | MP0009780_abnormal_chondrocyte_physiolo | 0.24553734 |
128 | MP0002135_abnormal_kidney_morphology | 0.24363381 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.58389590 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.32939611 |
3 | Intrahepatic cholestasis (HP:0001406) | 7.29655166 |
4 | Prolonged partial thromboplastin time (HP:0003645) | 6.79072198 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.64184949 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.46455350 |
7 | Xanthomatosis (HP:0000991) | 6.33796314 |
8 | Complement deficiency (HP:0004431) | 5.68089887 |
9 | Hyperlipoproteinemia (HP:0010980) | 5.62364416 |
10 | Joint hemorrhage (HP:0005261) | 4.99783292 |
11 | Hypolipoproteinemia (HP:0010981) | 4.91547877 |
12 | Hyperammonemia (HP:0001987) | 4.56896096 |
13 | Epidermoid cyst (HP:0200040) | 4.54433580 |
14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.49637291 |
15 | * Abnormality of the common coagulation pathway (HP:0010990) | 4.48912143 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.36442383 |
17 | Hyperglycinemia (HP:0002154) | 4.34727314 |
18 | Abnormality of methionine metabolism (HP:0010901) | 4.28818997 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23336862 |
20 | Ketosis (HP:0001946) | 4.17322546 |
21 | Abnormality of complement system (HP:0005339) | 4.15576096 |
22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.13402708 |
23 | Fat malabsorption (HP:0002630) | 4.12702396 |
24 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12179299 |
25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.90882422 |
26 | Hypoglycemic coma (HP:0001325) | 3.85513907 |
27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82800238 |
28 | Abnormality of glycine metabolism (HP:0010895) | 3.82800238 |
29 | Hyperglycinuria (HP:0003108) | 3.79954025 |
30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78932774 |
31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72252929 |
32 | Hypercholesterolemia (HP:0003124) | 3.63946570 |
33 | Hyperbilirubinemia (HP:0002904) | 3.33547261 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.25981805 |
35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23218328 |
36 | Hypochromic microcytic anemia (HP:0004840) | 3.05909202 |
37 | Steatorrhea (HP:0002570) | 3.05534486 |
38 | Hepatocellular carcinoma (HP:0001402) | 3.03741996 |
39 | Abnormality of serum amino acid levels (HP:0003112) | 3.02560649 |
40 | Myocardial infarction (HP:0001658) | 3.00513994 |
41 | Delayed CNS myelination (HP:0002188) | 2.99302366 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98854554 |
43 | Ketoacidosis (HP:0001993) | 2.93902936 |
44 | Osteomalacia (HP:0002749) | 2.91489381 |
45 | Systemic lupus erythematosus (HP:0002725) | 2.86324175 |
46 | * Spontaneous abortion (HP:0005268) | 2.81591242 |
47 | Skin nodule (HP:0200036) | 2.81553812 |
48 | Acanthocytosis (HP:0001927) | 2.73016377 |
49 | Metabolic acidosis (HP:0001942) | 2.70104123 |
50 | Glomerulonephritis (HP:0000099) | 2.70087128 |
51 | Amyloidosis (HP:0011034) | 2.67521393 |
52 | Abnormality of purine metabolism (HP:0004352) | 2.58815445 |
53 | Purpura (HP:0000979) | 2.56416496 |
54 | Lethargy (HP:0001254) | 2.54763832 |
55 | Vascular calcification (HP:0004934) | 2.53833899 |
56 | Hypoglycemic seizures (HP:0002173) | 2.51163310 |
57 | Abnormal gallbladder morphology (HP:0012437) | 2.49467365 |
58 | Dicarboxylic aciduria (HP:0003215) | 2.47729223 |
59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.47729223 |
60 | Spastic diplegia (HP:0001264) | 2.47023707 |
61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46535757 |
62 | Cholelithiasis (HP:0001081) | 2.44306254 |
63 | Abnormal gallbladder physiology (HP:0012438) | 2.40209064 |
64 | Cholecystitis (HP:0001082) | 2.40209064 |
65 | Mitral stenosis (HP:0001718) | 2.39994705 |
66 | Gout (HP:0001997) | 2.38766102 |
67 | Cerebral edema (HP:0002181) | 2.37498653 |
68 | Irritability (HP:0000737) | 2.32198006 |
69 | Neonatal onset (HP:0003623) | 2.31378308 |
70 | Esophageal varix (HP:0002040) | 2.27730100 |
71 | Cardiovascular calcification (HP:0011915) | 2.25012714 |
72 | Malnutrition (HP:0004395) | 2.24991419 |
73 | Menorrhagia (HP:0000132) | 2.24077400 |
74 | Arthropathy (HP:0003040) | 2.18473639 |
75 | Poikilocytosis (HP:0004447) | 2.14011176 |
76 | Sensorimotor neuropathy (HP:0007141) | 2.13277309 |
77 | Pancreatitis (HP:0001733) | 2.12709112 |
78 | Enlarged kidneys (HP:0000105) | 2.11267401 |
79 | * Gingival bleeding (HP:0000225) | 2.10878361 |
80 | Late onset (HP:0003584) | 2.09882774 |
81 | Fair hair (HP:0002286) | 2.07754706 |
82 | Brushfield spots (HP:0001088) | 2.06669443 |
83 | * Thrombophlebitis (HP:0004418) | 2.04534904 |
84 | * Joint swelling (HP:0001386) | 2.04347927 |
85 | Retinal atrophy (HP:0001105) | 2.04307722 |
86 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03877444 |
87 | Hemorrhage of the eye (HP:0011885) | 2.03292426 |
88 | Vomiting (HP:0002013) | 2.03030116 |
89 | Abnormality of the gallbladder (HP:0005264) | 2.01476161 |
90 | Increased serum ferritin (HP:0003281) | 1.99524356 |
91 | Abnormality of iron homeostasis (HP:0011031) | 1.98136923 |
92 | Abnormal tarsal ossification (HP:0008369) | 1.97864285 |
93 | Opisthotonus (HP:0002179) | 1.97607272 |
94 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94604566 |
95 | Generalized aminoaciduria (HP:0002909) | 1.93954965 |
96 | Abnormality of urine glucose concentration (HP:0011016) | 1.90574625 |
97 | Glycosuria (HP:0003076) | 1.90574625 |
98 | Hyperphosphaturia (HP:0003109) | 1.90381911 |
99 | Abnormality of the Achilles tendon (HP:0005109) | 1.90330729 |
100 | Rickets (HP:0002748) | 1.89034355 |
101 | Elevated alkaline phosphatase (HP:0003155) | 1.88810550 |
102 | Nephritis (HP:0000123) | 1.88585259 |
103 | Increased serum pyruvate (HP:0003542) | 1.85463751 |
104 | Hypophosphatemic rickets (HP:0004912) | 1.84894395 |
105 | Abnormal cartilage morphology (HP:0002763) | 1.81588509 |
106 | Elevated hepatic transaminases (HP:0002910) | 1.81431593 |
107 | Abnormality of vitamin metabolism (HP:0100508) | 1.80524567 |
108 | * Abnormal delivery (HP:0001787) | 1.79976150 |
109 | Hydroxyprolinuria (HP:0003080) | 1.78925988 |
110 | Abnormality of proline metabolism (HP:0010907) | 1.78925988 |
111 | Renal cortical cysts (HP:0000803) | 1.78209068 |
112 | Status epilepticus (HP:0002133) | 1.77704008 |
113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.77616266 |
114 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76891436 |
115 | Alkalosis (HP:0001948) | 1.76729432 |
116 | * Epistaxis (HP:0000421) | 1.75193941 |
117 | Pulmonary embolism (HP:0002204) | 1.73421064 |
118 | Reduced antithrombin III activity (HP:0001976) | 1.71765589 |
119 | Hyperglycemia (HP:0003074) | 1.70945953 |
120 | Neonatal hypoglycemia (HP:0001998) | 1.59712789 |
121 | Abnormality of glycolysis (HP:0004366) | 1.58949601 |
122 | Proximal tubulopathy (HP:0000114) | 1.57284181 |
123 | Abnormal urine phosphate concentration (HP:0012599) | 1.56434558 |
124 | Bifid scrotum (HP:0000048) | 1.54579987 |
125 | Cerebral palsy (HP:0100021) | 1.54221602 |
126 | Abnormality of carpal bone ossification (HP:0006257) | 1.53636893 |
127 | Potter facies (HP:0002009) | 1.51710528 |
128 | Facial shape deformation (HP:0011334) | 1.51710528 |
129 | Gangrene (HP:0100758) | 1.51582586 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 6.90699617 |
2 | ERN1 | 4.82676334 |
3 | FGFR4 | 4.75911927 |
4 | SIK1 | 4.31765461 |
5 | PDK2 | 3.77125299 |
6 | ERBB4 | 3.20320630 |
7 | TAOK3 | 3.08167397 |
8 | INSRR | 3.04946996 |
9 | PIK3CA | 2.49248116 |
10 | MAP2K4 | 2.31588791 |
11 | MST1R | 2.18304910 |
12 | PKN2 | 2.06683697 |
13 | MAPK11 | 2.04045664 |
14 | TRIB3 | 1.82726951 |
15 | MAP3K2 | 1.82248752 |
16 | TYK2 | 1.80547347 |
17 | NTRK3 | 1.80511406 |
18 | FLT3 | 1.79722968 |
19 | PIK3CG | 1.77721078 |
20 | LATS1 | 1.73066684 |
21 | AKT3 | 1.69431408 |
22 | PTK6 | 1.58690743 |
23 | DAPK2 | 1.57326714 |
24 | LMTK2 | 1.52401927 |
25 | NEK9 | 1.51241005 |
26 | PDGFRA | 1.50341710 |
27 | ABL2 | 1.43783866 |
28 | CDK12 | 1.36272637 |
29 | FRK | 1.35513507 |
30 | FGFR2 | 1.33466790 |
31 | KDR | 1.31753972 |
32 | JAK2 | 1.31272490 |
33 | WNK4 | 1.25794897 |
34 | MAP3K7 | 1.17252628 |
35 | FGFR1 | 1.16826106 |
36 | ERBB2 | 1.15931034 |
37 | NLK | 1.10981015 |
38 | JAK1 | 1.10896224 |
39 | PRKAA2 | 1.10181324 |
40 | GRK6 | 1.08349625 |
41 | ACVR1B | 1.08143455 |
42 | EPHA3 | 1.07743222 |
43 | EPHB1 | 1.06733694 |
44 | TBK1 | 1.04595002 |
45 | MAP2K3 | 1.03956304 |
46 | MAP3K12 | 1.03046215 |
47 | PINK1 | 1.02291338 |
48 | FER | 1.01626095 |
49 | MAPK4 | 0.96692121 |
50 | MAP3K10 | 0.95936689 |
51 | MAP3K14 | 0.94130845 |
52 | MET | 0.91006666 |
53 | PRKCZ | 0.87313623 |
54 | MAP3K3 | 0.86769148 |
55 | SCYL2 | 0.84104151 |
56 | TYRO3 | 0.83904692 |
57 | MAPK15 | 0.80403421 |
58 | CSNK1E | 0.79464080 |
59 | STK38L | 0.79028816 |
60 | CDK6 | 0.77708225 |
61 | TESK2 | 0.77546948 |
62 | EPHA2 | 0.77458185 |
63 | PRKACG | 0.77276743 |
64 | MAPK12 | 0.76913038 |
65 | MAP3K11 | 0.76311927 |
66 | CAMK2G | 0.74313890 |
67 | TIE1 | 0.73186391 |
68 | RIPK1 | 0.70954899 |
69 | PRKG1 | 0.70821909 |
70 | CAMK1D | 0.68561662 |
71 | GSK3A | 0.68433961 |
72 | DYRK1B | 0.67555755 |
73 | CSK | 0.67074391 |
74 | KSR2 | 0.67011617 |
75 | FGFR3 | 0.66591522 |
76 | PRKAA1 | 0.65100994 |
77 | MAPKAPK3 | 0.63933209 |
78 | BRSK2 | 0.63791553 |
79 | CSNK1D | 0.63035161 |
80 | EIF2AK3 | 0.61982324 |
81 | SGK3 | 0.61419776 |
82 | EIF2AK1 | 0.58740113 |
83 | TGFBR2 | 0.58628639 |
84 | MAP2K6 | 0.57994212 |
85 | PTK2 | 0.56679270 |
86 | CASK | 0.55142858 |
87 | MAPK7 | 0.54752154 |
88 | IKBKE | 0.53471970 |
89 | CSF1R | 0.53470729 |
90 | CAMKK2 | 0.51945246 |
91 | IRAK3 | 0.51920112 |
92 | RPS6KB1 | 0.51770630 |
93 | PKN1 | 0.50644478 |
94 | PDPK1 | 0.49019475 |
95 | PRKCB | 0.48559887 |
96 | PRKACA | 0.48429114 |
97 | PRKCQ | 0.47554924 |
98 | NEK1 | 0.45956724 |
99 | MAP3K5 | 0.45188654 |
100 | SGK2 | 0.45073981 |
101 | SRC | 0.44565478 |
102 | MAP2K1 | 0.44443984 |
103 | CSNK2A1 | 0.44204255 |
104 | CSNK2A2 | 0.43761938 |
105 | CSNK1G1 | 0.42606699 |
106 | RET | 0.42459528 |
107 | GRK1 | 0.42122866 |
108 | IGF1R | 0.41774424 |
109 | SGK1 | 0.40204201 |
110 | MAP3K6 | 0.39078496 |
111 | MAP3K13 | 0.38989801 |
112 | CDK4 | 0.38773554 |
113 | TAOK2 | 0.38469376 |
114 | EPHA4 | 0.38377443 |
115 | PRKCG | 0.38085145 |
116 | RPS6KA3 | 0.37864434 |
117 | EEF2K | 0.37749857 |
118 | MTOR | 0.37479187 |
119 | EGFR | 0.35903160 |
120 | PDGFRB | 0.34871210 |
121 | ICK | 0.33721591 |
122 | PBK | 0.33646168 |
123 | SGK223 | 0.31770295 |
124 | SGK494 | 0.31770295 |
125 | CAMK4 | 0.30957080 |
126 | MAP3K1 | 0.30665586 |
127 | PRPF4B | 0.30215772 |
128 | BCR | 0.29503345 |
129 | ZAP70 | 0.29264739 |
130 | IRAK1 | 0.29128323 |
131 | PDK1 | 0.28312515 |
132 | LATS2 | 0.25619172 |
133 | PRKCA | 0.24299580 |
134 | BMX | 0.23131458 |
135 | PAK3 | 0.23025986 |
136 | CAMK1G | 0.22052911 |
137 | ABL1 | 0.21881121 |
138 | CSNK1G2 | 0.20716029 |
139 | PRKACB | 0.20488945 |
140 | MAP2K2 | 0.19284159 |
141 | MAPK3 | 0.17723415 |
142 | CSNK1G3 | 0.17234811 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.51204332 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.81495294 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46487021 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.26339413 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.14036056 |
6 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.93701949 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67589307 |
8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64232175 |
9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63819633 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57610626 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47777824 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34026321 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16220074 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11614857 |
15 | Peroxisome_Homo sapiens_hsa04146 | 2.05768754 |
16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04799481 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.93774537 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89059035 |
19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88706143 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88476521 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86660012 |
22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85617679 |
23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83624306 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79857495 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77610441 |
26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.71736526 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67681809 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67333366 |
29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.63193243 |
30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61948758 |
31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60085832 |
32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.59491625 |
33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56846512 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52434638 |
35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50972378 |
36 | Bile secretion_Homo sapiens_hsa04976 | 1.47720732 |
37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44226270 |
38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34769312 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33373681 |
40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31136160 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29989940 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24286141 |
43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22952547 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22365623 |
45 | ABC transporters_Homo sapiens_hsa02010 | 1.21031218 |
46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20615043 |
47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19517715 |
48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13094965 |
49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03626708 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02292816 |
51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98859990 |
52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98129313 |
53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98032518 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94795296 |
55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93870528 |
56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89933767 |
57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88825761 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84696870 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.80493361 |
60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.78739730 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69340599 |
62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65842234 |
63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62109736 |
64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59980225 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53050115 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45408828 |
67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45225660 |
68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44019032 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.39301340 |
70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38668311 |
71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26519137 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25260982 |
73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24486594 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.24272117 |
75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23649052 |
76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20497374 |
77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20296176 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16316107 |
79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10622315 |
80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.04932869 |
81 | Mineral absorption_Homo sapiens_hsa04978 | 0.02989411 |
82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02284917 |
83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.01877461 |
84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2407917 |
85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2319859 |
86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2297636 |
87 | Pertussis_Homo sapiens_hsa05133 | -0.2277225 |
88 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2166028 |
89 | Bladder cancer_Homo sapiens_hsa05219 | -0.2147818 |
90 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1988575 |
91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1914379 |
92 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1859915 |
93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1812363 |
94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1697505 |
95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1661225 |
96 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1633652 |
97 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.1586718 |
98 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1547160 |
99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1543410 |
100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1501610 |
101 | Hepatitis C_Homo sapiens_hsa05160 | -0.1482448 |
102 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1293825 |
103 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1022713 |
104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0739437 |
105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0736142 |
106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0729563 |
107 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0711312 |
108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0591846 |